[ad_1]
Antibody drug distribution to patients with new coronavirus The United States is expected to start on weekends. This is the drug produced by the company. Eli Lilly and Co LLY.N COVID-19, which will be distributed to state health services, said Secretary of the Ministry of Health and Human Services (HHS) Alex Azar.
“Early treatment can help people avoid disease and not need hospitalization,” said Janet Woodcock, its director. Center for Drug Research and Evaluation, in a videoconference with Azar.
THE FDA on Monday it issued emergency licenses for Lilly’s drug to patients 65 and older who were recently diagnosed with mild to moderate COVID-19 and to patients 12 and older who have an underlying disease. The FDA has emphasized that the treatment should not be used in patients who have already been treated with COVID-19.
the HHS will distribute the drug, bamlanivimab, using a system developed over the summer to deliver remdesivir, an antiviral drug developed by Gilead Sciences Inc. GILD.O, approved for use in hospital patients with COVID-19.
Bamlanivimab distributions in states and territories will be based on the number of COVID-19 hospital patients and the total number of cases, government officials said.
Bamlanivimab has been shown to reduce the risk of hospitalization in intensive care units.
The United States has purchased 300,000 doses of the treatment. for the current year and you have the option to purchase an additional 650,000 installments for the next year.
Drug distributor AmerisourceBergen Corp ABC.N will initially deliver the biotech drug to hospitals, but the goal is to expand its distribution.
News Today
New Turkish challenge: Navtex calls for the demilitarization of Samothrace, Lemnos, Chios and Samos
How we got to the “hair pull” of Erdogan’s son-in-law with the new governor of the Central Bank of Turkey
Ezia Brands: Miss USA 2020 is African American and … Trump fan
